More than 200 people with diabetes were injured after technology defect caused their insulin pump to unexpectedly shut down, according to the Food and Drug Administration. The software glitch has ...

The U.S. Food and Drug Administration has issued a Class I "most serious type of recall" for an iOS app used in conjunction with an insulin pump. The "correction" as referred to by the FDA on ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New automated insulin delivery pumps have significantly improved diabetes care, ...

MARKHAM, Ontario--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ ...

The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

Though the smallest of Medtronic’s four core businesses, the diabetes department has taken center stage as of late. Fresh off reaching a resolution with the FDA over a warning letter concerning its ...

When Lindsay Tabacchini hangs upside-down off the sofa, her tummy pokes out and you can see the little black case that’s fastened around her waist. Slightly larger than a beeper, the device is an ...

The maker of a new category of small, wearable insulin patch pumps—designed to comfortably provide therapy to people with diabetes while they sleep—has raised $23.6 million in early venture capital to ...